Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
492
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
-4.58M
-
Total reported value, excl. options
-
$16.8B
-
Value change
-
-$859M
-
Put/Call ratio
-
0.61
-
Number of buys
-
259
-
Number of sells
-
-208
-
Price
-
$149.45
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2024
606 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2024.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 492 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 132M outstanding shares and own 85.44% of the company stock.
Largest 10 shareholders include Capital World Investors (12.8M shares), VANGUARD GROUP INC (12M shares), FMR LLC (9.97M shares), BlackRock Inc. (9.03M shares), WELLINGTON MANAGEMENT GROUP LLP (7.21M shares), BAILLIE GIFFORD & CO (6.62M shares), Dodge & Cox (3.81M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.69M shares), Capital International Investors (3.65M shares), and STATE STREET CORP (3.19M shares).
This table shows the top 492 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.